Oral budesonide is as effective as oral prednisolone in active Crohn's disease

Gut

Volumn 41, Issue 2, 1997, Pages 209-214

  Campieri, M ^a,e   Ferguson, A ^b   Doe, W ^c   Persson, T ^d   Nilsson, L G ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Biology and Environment   (Australia)

^d ASTRAZENECA R AND D   (Sweden)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adrenal function; CDAI; Glucocorticoid; Glucocorticoid associated side effects

Indexed keywords

BUDESONIDE; CORTICOTROPIN; GLUCOCORTICOID; PREDNISOLONE;

ADOLESCENT; ADRENAL FUNCTION; ADULT; ARTICLE; ASCENDING COLON; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; CROHN DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DYSPEPSIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; ILEUM; MAJOR CLINICAL STUDY; MALE; MOON FACE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 0030870541     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.2.209     Document Type: Article

References (21)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991; 325: 1008 16.
2. Meyers S, Sachar DB. Medical management of Crohn's disease. Hepatogastroenterology 1990; 37: 42 55.
3. Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
4. Brattsand R. Overview of newer glucocorticoid preparations for inflammatory bowel disease. Can J Gastroenterol 1990; 4: 407 14.
5. Brogden RN, McTavish D, Barnes P J, Gross NJ, Juniper E, Laursen LC, et al. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44: 375 407.
6. The Danish Budesonide Study Group. Budesonide enema in distal ulcerative colitis: a randomized dose-response trial with predinsolone enema as positive control. Scand J Gastroenterol 1991; 26: 1225 30.
7. Löfberg R, Østergaard-Thomsen O, Langholz, M, Schioeler R, Danielsson AA, Suhr O, et al. Budesonide versus prednisolone retention enema in active distal ulcerative colitis. Aliment Pharmacol Ther 1994; 8: 623 9.
8. Bianchi Porro G, Prantera C, Campieri M, Petrillo M, Campanini MC, Gionchetti P, et al. Comparative trial of methylprednisolone and budesonide enema in active distal ulcerative colitis. Eur J Gastroenterol Hepatol 1994; 6: 125 30.
9. Tarpila S, Turunen U, Seppala K, Aukee S, Pikkarainen P, Elomaa I, et al. Budesonide enema is as effective as hydrocortisone foam in proctitis. Aliment Pharmacol Ther 1994; 8: 591 5.
10. Edsbäcker S, Wollmer P, Nilsson A, Nilsson M. Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules. Gastroenterology 1993; 104: A695.
11. Löfberg R, Danielsson A, Salde L. Oral budesonide in active Crohn's disease. Aliment Pharmacol Ther 1993; 7: 611-6.
12. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 836-41.
13. Rutgeerts P, Löfberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842 5.
14. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
15. Ögren L, Jönsson P. Determination of cortisol in human plasma by solid phase extraction and coupled column liquid chromatography. Astra Draco Report 850-RD-0323, 1994.
16. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66.
17. Hanauer SB, Stathopoulos G. Risk-benefit assessment of drug used in the treatment of inflammatory bowel disease. Drug Saf 1991; 6: 192-219.
18. Reinberg A, Smolensky MH, D'Alonzo GE, Mc Govern JP. Chronobiology and asthma III. Timing corticotherapy to biological rhythms to optimize treatment goals. J Asthma 1988; 25: 219-48.
19. Faucy AS, Dale DC, Balow JE. Glucocorticoid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976; 84: 304-15.
20. Edsbäcker S, Larsson P, Nilsson M, Wirén JE. Budesonide controlled ileal release (CIR) capsules affect plasma cortisol less than prednisolone. Gastroenterology 1995; 108: A814.
21. Sachar DB. Budesonide for inflammatory bowel disease: is it a magic bullet? N Engl J Med 1994; 331: 873-4.